Gonococcal antimicrobial resistance in the Western Pacific Region

Sexually Transmitted Infections

Volumn 89, Issue SUPPL. 4, 2013, Pages

  Lahra, Monica M ^a,b   Lo, Ying Ru ^c   Whiley, David M ^d,e  

^a WHO COLLABORATING CENTRE FOR REFERENCE AND RESEARCH ON INFLUENZA   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c The World Health Organization Regional Office for the Western Pacific philippines   (Philippines)

^d LADY CILENTO CHILDREN S HOSPITAL   (Australia)

^e UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC RESISTANCE; ARTICLE; DRUG SURVEILLANCE PROGRAM; GONORRHEA; HUMAN; NEISSERIA GONORRHOEAE; PRIORITY JOURNAL; WORLD HEALTH ORGANIZATION;

ANTIBIOTIC RESISTANCE; GONOCOCCI; GONORRHOEA; SURVEILLANCE;

ANTI-BACTERIAL AGENTS; AUSTRALASIA; DRUG RESISTANCE, BACTERIAL; GONORRHEA; HUMANS; INTERNATIONAL COOPERATION; MICROBIAL SENSITIVITY TESTS; NEISSERIA GONORRHOEAE; SENTINEL SURVEILLANCE;

EID: 84891842983     PISSN: 13684973     EISSN: 14723263     Source Type: Journal    
DOI: 10.1136/sextrans-2012-050906     Document Type: Article

References (30)

1. WHO. WHO in the Western Pacific: In brief. Secondary WHO in the Western Pacific: In brief 2012. http://www.wpro.who.int/about/in-brief/en/
2. WHO, Unicef. Global HIV/AIDS response: Epidemic update & health sector progress towards universal access. Progress report November, 2011.
3. WHO. 11 Health Questions about the 11 SEAR Countries. New Delhi, India 2007.
4. Tapsall J. Antibiotic resistance in Neisseria gonorrhoeae is diminishing available treatment options for gonorrhea: Some possible remedies. Expert Rev Anti Infect Ther 2006;4:619-28. (Pubitemid 44523940)
5. Barry P, Klausner J. The use of cephalosporins for gonorrhea: The impending problem of resistance. Expert Opin Pharmacother 2009;10:555-77.
6. Lewis DA. The Gonococcus fights back: Is this time a knock out? Sex Transm Infect 2010;86:415-21.
7. Deguchi T, Nakane K, Yasuda M, et al. Emergence and spread of drug resistant Neisseria gonorrhoeae. J Urol 2010;184:851-8.
8. Tapsall JW. Neisseria gonorrhoeae and emerging resistance to extended spectrum cephalosporins. Curr Opin Infect Dis 2009;22:87-91.
9. Chisholm SA, Mouton JW, Lewis DA, et al. Cephalosporin MIC creep among gonococci: Time for a pharmacodynamic rethink? J Antimicrob Chemother 2010;65:2141-48.
10. Unemo M, Golparian D, Nicholas R, et al. High-level cefixime-and ceftriaxone-resistant Neisseria gonorrhoeae in France: Novel penA mosaic allele in a successful international clone causes treatment failure. Antimicrob Agents Chemother 2012;56:1273-80.
11. Ohnishi M, Golparian D, Shimuta K, et al. Is Neisseria gonorrhoeae initiating a future era of untreatable gonorrhea?: Detailed characterization of the first strain with high-level resistance to ceftriaxone. Antimicrob Agents Chemother 2011;55: 3538-45.
12. Whiley DM, Goire N, Lahra MM, et al. The ticking time bomb: Escalating antibiotic resistance in Neisseria gonorrhoeae is a public health disaster in waiting. J Antimicrob Chemother 2012;67:2059-61.
13. Anonymous. Surveillance of antibiotic susceptibility of Neisseria gonorrhoeae in the WHO Western Pacific Region 1992-4. WHO Western Pacific Region Gonococcal Antimicrobial Surveillance Programme. 1997.
14. Tapsall JW, Ndowa F, Lewis DA, et al. Meeting the public health challenge of multidrug-and extensively drug-resistant Neisseria gonorrhoeae. Expert Rev Anti Infect Ther 2009;7:821-34.
15. Tapsall JW. Implications of current recommendations for third-generation cephalosporin use in the WHO Western Pacific Region following the emergence of multiresistant gonococci. Sex Transm Infect 2009;85:256-8.
16. Unemo M, Fasth O, Fredlund H, et al. Phenotypic and genetic characterization of the 2008 WHO Neisseria gonorrhoeae reference strain panel intended for global quality assurance and quality control of gonococcal antimicrobial resistance surveillance for public health purposes. 2009.
17. Lahra MM. Surveillance of antibiotic resistance in Neisseria gonorrhoeae in the WHO Western Pacific and South East Asian Regions, 2010 Communicable Diseases Intelligence Volume 36 No 1-March 2012, 2012.
18. Zheng H-P, Yang B, Wu X-Z, et al. Increase of African-type penicillinase-producing N. gonorrhoeae strains isolated in Guangzhou, China, 2001-2011 XVIIIth International Pathogenic Neisseria Conference. Germany, 2012.
19. Su X, Jiang F, Qimuge, et al. Surveillance of antimicrobial susceptibilities in Neisseria gonorrhoeae in Nanjing, China, 1999-2006. 2007.
20. Programme AGS. Annual report of the Australian Gonococcal Surveillance Programme, 2005. 2006.
21. Cámara J, Serra J, Ayats J, et al. Molecular characterization of two high-level ceftriaxone-resistant Neisseria gonorrhoeae isolates detected in Catalonia, Spain. J Antimicrob Chemother 2012;67:1858-60.
22. Lahra M. Australian Gonococcal Surveillance Programme Annual Report, 2010. Commun Dis Intell 2011;35:229-36.
23. Siedner MJ, Pandori M, Castro L, et al. Real-time PCR assay for detection of quinolone-resistant Neisseria gonorrhoeae in urine samples. J Clin Microbiol 2007;45:1250-54. (Pubitemid 46626493)
24. Goire N, Freeman K, Tapsall JW, et al. Enhancing gonococcal antimicrobial resistance surveillance: A real-time PCR assay for detection of penicillinase-producing Neisseria gonorrhoeae by use of noncultured clinical samples. J Clin Microbiol 2011;2:513-18.
25. Goire N, Ohnishi M, Limnios AE, et al. Enhanced gonococcal antimicrobial surveillance in the era of ceftriaxone resistance: A real-time PCR assay for direct detection of the Neisseria gonorrhoeae H041 strain. J Antimicrob Chemother 2012;67:902-05.
26. Morgan DJ, Okeke IN, Laxminarayan R, et al. Non-prescription antimicrobial use worldwide: A systematic review. 2011.
27. WHO. Prevention and treatment of HIV and other sexually transmitted infections among men who have sex with men and transgender people. Recommendations for a public health approach.: Geneva, Switzerland: WHO Document Production Services, 2011.
28. Gu Y, Kaku M. How can we fight against antimicrobialresistant bacteria in the World Health Organization Western Pacific Region? Western Pacific Surveil Response J 2012;3:1-3.
29. Ameyama S, Onodera S, Takahata M, et al. Mosaic-like structure of penicillin-binding protein 2 Gene (penA) in clinical isolates of Neisseria gonorrhoeae with deduced susceptibility to cefixime. Antimicrob Agents Chemother 2002;46:3744-49. (Pubitemid 35403246)
30. WHO. Global action plan to control the spread and impact of antimicrobial resistance in Neisseria gonorrhoeae. WHO Department of Reproductive Health and Research, 2012.